Inventor · disambiguated record
Nupura Bhise
Also filed as: BHISE NUPURA · BHISE NUPURA S
7 granted patents·10 pending applications·19 citations·filing 2010–2025
81Inventor score
Top patents by PatentIndex Score
17 records- 0185US2025136737A1Multicomponent degradable cationic polymersUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0284US12023406B2Gastric residence systems with release rate-modulating filmsLYNDRA THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2024·2 cites·57 claims
- 0384US9884118B2Multicomponent degradable cationic polymersUNIV JOHNS HOPKINS·Filed 2015·Granted Feb 6, 2018·4 cites·17 claims
- 0482US12109305B2Materials architecture for gastric residence systemsLYNDRA THERAPEUTICS INC·Filed 2017·Granted Oct 8, 2024·3 cites·34 claims
- 0582US11576866B2Gastric residence systems for sustained delivery of adamantane-class drugsLYNDRA THERAPEUTICS INC·Filed 2017·Granted Feb 14, 2023·5 cites·22 claims
- 0678US8992991B2Multicomponent degradable cationic polymersGREEN JORDAN J·Filed 2010·Granted Mar 31, 2015·5 cites·4 claims
- 0776US2024423909A1Materials architecture for gastric residence systemsLYNDRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0874US2024382418A1Gastric residence systems with release rate-modulating filmsLYNDRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0973US12049530B2Multicomponent degradable cationic polymersUNIV JOHNS HOPKINS·Filed 2021·Granted Jul 30, 2024·0 cites·8 claims
- 1073US2020297851A1Multicomponent degradable cationic polymersUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1165US2025332111A1Capsules and capsule coatings for gastric residence dosage formsLYNDRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1261US2018177881A1Multicomponent Degradable Cationic PolymersUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 1358US12447130B2Capsules and capsule coatings for gastric residence dosage formsLYNDRA THERAPEUTICS INC·Filed 2020·Granted Oct 21, 2025·0 cites·20 claims
- 1455US2024252483A1Gastric residence systems comprising buprenorphine and naloxoneLYNDRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1553US2024390270A1Gastric residence systems for administration of risperidoneLYNDRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1649US2022387312A1Gastric residence systems having arms with controlled stiffness for improved gastric residenceLYNDRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1747US2022387311A1Gastric residence systems for administration of active agentsLYNDRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →